Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.
about
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systemsDevelopment of Sustained Release "NanoFDC (Fixed Dose Combination)" for Hypertension - An Experimental StudyRecent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers.Current advances in research and clinical applications of PLGA-based nanotechnology.Evaluating the feasibility of utilizing the small molecule phenamil as a novel biofactor for bone regenerative engineering.Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient miceTuning core vs. shell dimensions to adjust the performance of nanoscopic containers for the loading and release of doxorubicinNanocarriers for nitric oxide delivery.Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheres.Drug delivery systems: An updated reviewAdvanced materials and processing for drug delivery: the past and the future.Nitric oxide and cancer: a review.Gold nanostructures as a platform for combinational therapy in future cancer therapeutics.Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro/nanoparticles.Metallic nanoparticles: technology overview & drug delivery applications in oncology.Extended release formulations for local anaesthetic agents.Intravitreal devices for the treatment of vitreous inflammation.IL-1Ra and its delivery strategies: inserting the association in perspective.The application of microencapsulation techniques in the treatment of endodontic and periodontal diseases.Cell microencapsulation with synthetic polymers.PLGA: a unique polymer for drug delivery.Current knowledge on biodegradable microspheres in drug delivery.Evaluation of Lapatinib Powder-Entrapped Biodegradable Polymeric Microstructures Fabricated by X-Ray Lithography for a Targeted and Sustained Drug Delivery SystemPoly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors.New platform for controlled and sustained delivery of the EGF receptor tyrosine kinase inhibitor AG1478 using poly(lactic-co-glycolic acid) microspheres.Controlled initial surge despite high drug fraction and high solubility.Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use.Improvement of the inhibitory effect of xanthones on NO production by encapsulation in PLGA nanocapsules.Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.Colloidal Gold-Mediated Delivery of Bleomycin for Improved Outcome in Chemotherapy.Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.Preparation and evaluation of microspheres prepared from novel polyester-ibuprofen conjugates blended with non-conjugated ibuprofen.In Vitro and In Vivo preparation evaluations of bleomycin implants and microspheres Prepared with DL-poly (lactide-co-glycolide).Effect of additives on stability of etoposide in PLGA microspheres.Metallo-Supramolecular initiators for the preparation of novel functional architectures.In-vitro release of fluoropyrimidines from PLGA film implants.Some basic parameters of microspheres fabricated from a branched oligoester by a rapid procedure.
P2860
Q28395046-65E3768B-2C28-4EA3-9DFB-27F14576C32EQ28547914-457C003C-58E9-4B20-B78D-FADB3A9E3899Q30329989-6FCA99FE-292A-47B6-A434-926D266E1095Q30482916-A2788114-7CD2-45FC-B73F-FA1072366DAEQ34344443-D77D4943-F71D-4AE3-B58E-13C336C548CFQ34377939-0487AA90-3C2E-40B1-9AF8-CB4C8CFE2E7FQ34506953-5B613511-F68E-4114-B650-6E06444B8D0FQ35058263-138D58DC-5F99-4542-88C8-70F858456E9EQ35176430-75D28BD3-A858-4555-93A2-97020A304C58Q35694277-B1472652-5C5F-4478-9095-54862C5B0247Q36300205-286E4C57-20DB-4CBD-A764-51AFFD40DDEEQ36589333-DBA40236-6D08-4BA8-BB0B-5349C6AD4086Q36893209-87ECF029-2F20-49F2-A8E2-730EF30F90F7Q37129853-A832451F-EA73-4A1E-84ED-1E56EA22D3ADQ37149102-29E17953-D264-4463-91C2-C75264E6E916Q37378031-CE61838E-DDF1-4712-A7FB-734F1E842593Q37709421-39E1FA45-B887-4A9A-9A26-969F86A21018Q37774342-4DE649D6-CAE4-4DC6-9F05-4ECC4E2DD6F7Q38011267-5FD74837-F27E-4D73-88B4-02A5E08512BBQ38044373-2AC6922D-FECD-4021-8B40-55D4351C7BCDQ38116457-3AB7B4EC-75EB-4E37-A58C-22B81AD9B452Q38169084-013207DB-6C86-4289-B3CF-52FB09D67B80Q38207569-230D8833-F68D-4746-B224-CE6E07984CB6Q38309875-8A6DF00F-BBED-47E0-B911-3241F3C483D8Q38357497-84AA15D3-EF2F-4633-A545-B6219270C4A6Q38634426-EA8A9B91-9E3B-4716-B30D-880ED55C595BQ39004808-CF79BEFE-6824-4535-AD90-BA998823A1B8Q39754858-0B9A618C-EF0B-4A6A-80CF-3E0EE0455BB6Q39983846-AEE12DC5-1A6E-4F3C-B657-322B65A06A85Q40230892-16374A38-7C3B-4F12-BC7E-FF301E92B03AQ40436522-12184413-DA79-48B3-BE2A-6AE7F2D49AA1Q40618965-3793AA08-B104-4ECE-B98E-0F9CB9826475Q41952431-BBE85236-2FFC-41A8-A92E-54602AB1C546Q41990628-F15BDBF8-31A8-4A4E-96FF-99B443438377Q43248724-5C8FF62C-FAD6-4B3C-8A44-25329D032B2EQ43579882-6B993EE0-222E-41FA-95CF-D2DAD15EA099Q43644527-84FE126C-C7D1-4A7E-9BC0-A92AD2FE595FQ43873306-A0976FD4-BEB5-4441-8A1E-322D877A808DQ44037977-E58A1DC5-2B3C-4664-9180-9FF5662064DDQ46372168-79666B52-F9E7-4C94-BB6E-1DC188C74A83
P2860
Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Controlled drug delivery by bi ...... ferent preparative approaches.
@en
type
label
Controlled drug delivery by bi ...... ferent preparative approaches.
@en
prefLabel
Controlled drug delivery by bi ...... ferent preparative approaches.
@en
P2093
P2860
P1476
Controlled drug delivery by bi ...... ferent preparative approaches.
@en
P2093
P2860
P304
P356
10.3109/03639049809082719
P407
P577
1998-08-01T00:00:00Z